Venture Capital News Daily Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
VC Directories Mobile Apps Celebrity VCs VentureTrackr Archive About Us
Venture Capital News Daily
Rani Therapeutics Raises $39M in Series D

SAN JOSE, CA, Rani Therapeutics has raised $39 million in Series D funding.
Click here for more funding data on Rani Therapeutics
To export Rani Therapeutics funding data to PDF and Excel, click here
According to published reports, Rani Therapeutics, has raised $39 million in Series D funding. Investors included GV, Novartis, Astra Zeneca, Cathay Ventures, Buttonwood, Crystal Horizon Investments, Pinemount Investments, the Pacific Venture Opportunity Fund and Bossa Nova Investments.

Rani Therapeutics has developed a novel approach for the oral delivery of large drug molecules including peptides, proteins and antibodies, which to date can only be delivered through injections.

The approach and technology for Rani Therapeutics was developed at InCube Labs, a multi-disciplinary life sciences R&D lab focused on developing breakthrough medical innovations.
(c)2011-2017 by Massinvestor, Inc. For contact info, please check out our about page.
  >> Click here for in-depth research on 4,000 VC firms
Venture Capital News Daily
Massinvestor/VC News Daily

© 2017 Massinvestor, Inc.